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SPECIFICITY  OF  CYTOTOXIC  EFFECTOR  CELLS 
DIRECTED  AGAINST  TRINITROBENZENE 
SULFONATE-MODIFIED  SYNGENEIC  CELLS 
Failure to Recognize 
Cell Surface-Bound Trinitrophenyl Dextran 
BY PIERRE A. HENKART, ANNE-MARIE SCHMITT-VERHULST, AND GENE M. SHEARER 
(From the Immunology Branch, National Cancer Institute, Bethesda, Maryland 20014) 
Cell-mediated lympholysis (CML)  1 has been generated in vitro against trini- 
trophenyl (TNP)-modified syngeneic murine spleen cells (1). The specificity of 
the effectors generated is such that the stimulater and target cells must beth be 
modified by the same agent (2, 3)1 and must also express the same H-2K and/or 
H-2D haplotypes (4, 5). In previous studies of the specificity of the CML effecters 
directed against TNP self, the modifying agents were coupled to cell surface 
proteins via covalent linkage, primarily to the amino groups of lysines (6). The 
present report describes experiments in which TNP stearoyl dextran was in- 
serted into the lipid bilayer of mouse spleen cells (used as sensitizing cells) and 
lymphoid tumor  cells  (used  as  target  cells)  for  the  generation of effectors 
directed against self-modified cells. The results indicate that when quantita- 
tively equivalent amounts of TNP are present on the cell surface either in the 
form of TNP stearoyl dextran (TSD) or as a result of direct covalent modification 
of the cell surface with trinitrobenzene sulfonate (TNBS),  only the latter is 
immunogenic for the generation of a  TNP self CML. Furthermore, the TSD- 
modified cells do not serve either as lysable targets or as inhibiting cells of 
effecters generated by sensitization with TNBS-modified syngeneic cells. 
Materials and Methods 
Mice.  The mice used  in the experiments were males 6-9  wk  of age.  Both the  B10.A  and 
B10.BR, as well as the AKR/J, mice were purchased from The Jackson Laboratory, Bar Harbor, 
Maine. 
In  Vitro  Cell  Culture,  TNP.Modification  of Cells,  and  5~Cr Release  Assay.  The  methods 
employed for the primary 5 day in vitro CML sensitization, the TNP modification of stimulating 
and target cells by covalent linkage of TNP, and the 4-h ~Cr release cytotoxic assay have been 
described in earlier publications (1, 4). For the covalent linkage of  TNP to cells, both 10 and 1 mM 
TNBS were used. See separate section for description of TNP dextran fatty acid insertion into cell 
surfaces. The target cells used for the 5~Cr-release assay and for the inhibition of lysis were RDM-4 
(1-1-2  k) lymphoid tumor cells carried as an ascites tumor in AKR/J mice. 
TSD.  TSD was synthesized by a modification of the procedure described elsewhere (6a). To 10 
1  Abbreviations  used in this paper:  CML, cell-mediated lympholysis; FITC, fluorescein isothio- 
cyanate; PBS, phosphate-buffered saline; TNBS, trinitrebenzene sulfonate; TNP, trinitrephenyl; 
TSD, TNP stearoyl dextran. 
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vol of 5 mg/ml N-(2-aminoethyl) carbamylmethyl dextran (mol wt = 82,500) (7) in 0.04 M sodium 
borate, pH 9.0, were added 4 vol of dimethyl formamide and 1 vol of the N-hydroxy succinimide 
ester of stearic acid (8) at 9. mg/ml in dimethylformamide. At~r 2 h at 37°C, the remaining amino 
groups were TNP modified by addition of 2 vol of  0.10 M TNBS in phosphate-buffered saline (PBS), 
pH 7.0.  After 2 h  at 37°C, the TSD was dialyzed in PBS and AG1  ×  8 (Bio-Rad Laboratories, 
Richmond, Calif.) beads at 5°C for 2 days.  Each molecule of TSD contains 42 TNP groups and 
approximately five stearate groups. 
Modification of Cells.  TNBS modification was carried out as described previously (1, 4); in 
some cases the TNBS concentration during modification was reduced from 10 to 1.0 or 0.1 raM. 
TSD modification was carried out by suspending a pellet of 107 cells in 100 ~1 Of TSD at 1-2 mg/ml 
in PBS.  After incubation at 37°C for 30 min, the cells were washed three times with culture 
medium. 
Irnrnunofluorescenee.  Anti-TNP was  prepared  by  affinity chromatography  on  DNP  lysine 
Sepharose  (Pharmacia  Fine  Chemicals Inc.,  Piscataway,  N.  J.)  from  the  serum  of a  sheep 
hyperimm-ni~ed with TNP keyhole limpet hemocyanin. After gel filtration on G200, the IgG 
fraction was labeled with 50 ~g fluorescein isothiocyanate (FITC)  per mg protein. F(ab')z frag- 
ments were prepared from the IgG fraction by pepsin digestion, and, after gel filtration on G200, 
labeled with 100 Izg FITC per mg protein. For staining of TNP-medified cells, 50 ~g of antibody 
was incubated with 5 ×  106 cells in 500 ~  of PBS containing 1% bovine serum albumin at 0°C. 
After washing once with cold PBS, the cells were fixed with 9.% paraformaldehyde in 0.125 M 
sodium cacedylate, pH 7.4, for 20 rain at room temperature, washed twice with PBS, and examined 
in the fluorescence microscope or by flow microfluorometry. 
Flow Microfluorometry.  Stained and fixed cells were suspended at -4  ×  106 ceUs/ml in PBS 
containing 10% fetal bovine serum. Flow microfluorometry was performed essentially as detailed 
by Loken and Herzenborg (9) by using a FACS I flow microfluorometer (Becton,  Dickinson Elec- 
tronics Laboratory, Mountain View, Calif.). A minimum of 40,000 cells were analysed, with light 
scatter gating used to eliminate damaged cells (>5%). The laser (model 164, Spectra-Physics Inc., 
Laser Products Div., Mountain View, Calif.) was focused on the cell stream with a 30-mm focal 
length spherical lens, by using a 488-nm line at a 500-mW light output. The data obtained by the 
FACS I were stored and analyzed by using a GT44 Data Acquisition System (Digital Equipment 
Corp., Marlboro, Mass.). 
Results 
Qualitative Estimation  of CeU Surface TNP Groups.  Under the conditions 
described, TSD molecules from solution adsorbed to cell surfaces, allowing cells 
to acquire TNP groups by a procedure which should not result in the chemical 
modification of other cell surface molecules. The acquisition of TNP groups can 
be easily demonstrated by immunofluorescence, and we have used the binding of 
FITC-anti-TNP to estimate the relative amounts of available cell surface TNP 
hapten per cell.  Fig.  1 shows the immunofluorescence of RDM~ tumor cells 
modified by TNBS at 10, 1, 0.1 raM, and by TSD. It is clear that the TSD-treated 
cells were approximately as bright as those cells treated with 10 mM TNBS. In 
other experiments the TSD-treated RDM-4 cells were of  intermediate brightness 
between those treated with 10 and 1 mM TNBS. Intact sheep IgG anti-T1VP and 
F(ab')2 fragments of this antibody gave identical results in these experiments. 
One qualitative difference between the anti-TNP staining of TSD- and TNBS- 
treated cells is the tendency of  the former to cap while the latter show little or no 
tendency to patch or cap.  This phenomenon has been studied intensively and 
will be reported elsewhere. All comparisons of anti-TNP immunofluorescence 
were made on cells stained at 0°C and fixed immediately. The tendency of the 
TSD molecules to patch even at 0°C can be seen in Fig.  1. 
TSD-treated spleen cells also acquired TNP groups on their surface. Immuno- 
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FIO.  1.  FITC-anti-TNP  staining of  TNP-modified  RDM-4  lymphoma  cells.  Tumor  cells 
were TNP-modified by four different  procedures, washed, stained with FITC-anti-TNP  at 
0°C, and fixed  with paraformaldehyde.  They were then photographed in the fluorescence 
microscope  under FITC-specific illumination by using identical  exposure times for  all  four 
types of  cells.  Subsequent photographic processing was likewise  identical  for  all  four  cases. 
The TNP modification conditions,  described in  the text,  are as  follows:  A, TSD; B, 10  mM 
TNBS; C, 1  mM  TNBS; D, 0.1 mM  TNBS. 
in having as much accessible cell surface TNP as those treated with 1-10 mM 
TNBS. In comparisons of the stability of  this cell surface TNP however, the TNP 
groups on TSD were less persistent. Although there was no detectable loss of 
TNP in either case after i h at 37°C, beth TNBS- and TSD-treated cells had less 
TNP after 24 h than before culture. However, the TSD-treated cells appeared to 
have lost the majority of their accessible TNP groups (anti-TNP staining was 
still significantly above the control level). The TNBS-treated cells exhibited a 
more modest loss. After 48 h in culture the TSD-treated cells appeared the same 
as at 24 h, whereas the TNBS-treated cells stained more faintly than they did at 
24 h, but were still somewhat brighter than the TSD cells al~r equal time in 
culture. RDM-4-TNP lymphoma cells modified by beth techniques showed more 
rapid loss of accessible surface TNP groups than spleen cells and their stability 
was studied quantitatively as described below. 
Quantitative Estimation of  CeU Surface TNP Groups. A quantitative compar- 
ison of relative anti-TNP fluorescence intensity of these cells by using flow 
microfluorometry confirmed the qualitative impression from fluorescence mi- 
croscopy. Fig. 2 shows the fluorescence intensity histograms for RDM-4-TNP cells 
made by modification with TSD, and 10, and 1 mM TNBS. Although this was a 
different experiment, the cells appeared microscopically similar to those shown P.  A.  HENKART,  A-M.  SCHMITT-VERHULST,  AND  G.  M.  SHEARER  1071 
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FIG.  2.  Flow microfluorometry of TNP-RDM-4  cells stained with FITC-anti-TNP.  Cells 
were modified and stained and fixed as in Fig. 1 except that in this experiment FITC F(ab')2 
anti-TNP antibody was used for staining. The histograms were run on the same gain. The 
channel number minus 40 is proportional to the fluorescence per cell. The cell populations 
are as follows, unmodified (  .....  ); 1 mM TNBS ( .....  ); 10 mM TNBS (- - -); TSD (  ). 
TABLE  I 
Quantitative FITC Anti-TNP Binding to TNP-Modified RDM-4 
Cells as Measured by Flow Microfluorometry* 
Mean fluores-  Percent of 
cence/cell  cells above 
TNP modification  Peak channel 
(Channel no.  channel no. 
-40)  900 
TNBS,  10 mM  353.5  221  5.6 
TNBS,  1 mM  107.7  76  1.3 
TSD  384.1  88  11.3 
None  6.3  45  <0.1 
* Calculated from the FACS profiles shown in Fig. 2. 
in Fig.  1,  and were also fixed immediately after staining  at 0°C.  Fig. 2 shows 
that the distribution of TNP groups per cell was much more heterogeneous in 
cells treated with TSD than in cells treated with TNBS. However, as shown in 
Table I, the mean anti-TNP fluorescence per cell was greater for TSD-treated 
cells than for 10 mM TNBS-treated cells, although the peak value in the TSD 
cell distribution curve lies between the peak values of the distribution curves for 
1 and 10 mM TNBS-treated cells. This was due to the presence of a substantial 
fraction (-30%) of the TSD-treated cells which were more intensely stained than 
the great majority (>90%) of the 10 mM TNBS-treated cells. 
The stability of the cell surface TNP groups on RDM-4 cells modified by the 1072  CELL-MEDIATED  LYMPHOLYSIS  SPECIFIC  TO  TRINITROPHENYL  SELF 
two different techniques was also examined over a 4-h culture period identical to 
that used in the CML assay (see below). The mean anti-TNP fluorescence per 
cell decreased to 85% of its original value for 1 mM TNBS-modified RDM-4 cells, 
and to 40% of its original value for TSD-modified RDM-4 cells. As can be seen 
from Table I this would still leave more average accessible TNP groups per cell 
on TSD-treated RDM-4 cells than on such cells treated with 1 mM TNBS. The 
possibility of enhanced TNP loss due to transfer of TSD from tumor target cells 
to cytotoxic effector cells during  the  CML assay incubations  (see below) was 
assessed by mixing unlabeled spleen cells with TSD- and TNBS-treated RDM'4 
cells at 10:1 and 40:1 ratios and incubating for 4 h.  By using the scatter gating 
capacity of the FACS to examine the fluorescence of only the large cells in these 
mixtures,  it was clear  that  the resulting  histograms  could be completely ac- 
counted for by assuming only the loss of TNP groups observed during culture of 
the tumor cells alone,  plus the contribution  of contaminating  large unlabeled 
spleen cells. 
Failure  of TSD-Modified  Cells to  Serve  as  Sensitizing  or  Target  Cells. To 
determine whether the TNP groups exposed on the cell surface by insertion of 
TSD into the lipid bilayer of cells would sensitize splenic lymphocytes to gener- 
ate cytotoxic effectors or would serve as targets of cytotoxicity, B10.BR spleen 
cells  were  synthesized  in  vitro  with  either  TNBS-modified  or  TSD-modified 
syngeneic spleen cells. The effector cells generated after 5 days of culture were 
assayed on 51Cr-labeled TNP-modified or TSD-modified RDM-4 target cells. The 
results, shown in Table II, indicate that sensitizing cells modified with TNBS at 
10 or  1 mM stimulated  the  development  of effector cells which  lysed TNBS- 
modified target  cells,  but which  did not lyse TSD-modified targets.  Further- 
more, when TSD-modified syngeneic sensitizing cells were used, no effector cells 
were  generated  which  lysed  either  TNBS-modified  or  TSD-modified  tumor 
target cells. The same result was verified in experiments by using the B10.A and 
C57BL/10 strains  (data  not shown).  This  result  was  also obtained  when  the 
cultures were restimulated with TSD-modified sensitizing cells 24 h aider initia- 
tion of sensitization (line 5 of Table II). It was verified that TSD-modified target 
cells are lysable in an allogeneic sensitization,  and did not detectably affect the 
interaction of effector cells with target cell alloantigens  (line 7 of Table II). 
To test cells bearing more stable surface TSD, TSD-modified spleen cells were 
also tested for their ability to be lysed by TSD- and TNBS-modified stimulating 
cells. As shown in the lower portion of Table II, such target cells were similar to 
TSD tumor cells in their  lack of lysis by effector cells raised against TSD- or 
TNP-syngeneic spleen cells. Furthermore,  as shown in the last line of Table II, 
modification of allogeneic stimulating cells with TSD had no detectable effect on 
the recognition of H-2  b alloantigens by B10.BR responding cells. 
Comparison  of Blocking  of Cytotoxicity against  TNP-Modified  Targets  with 
TNP-Modified and TSD-Modified Inhibiting  Cells.  Although  TSD-modified 
cells  were  not  immunogenic  for  the  generation  of a  self-modified  cytotoxic 
response, and were not lysable targets by effector cells generated in the TNBS- 
modified self CML (see Table II), the possibility existed that TSD-modified cells 
would specifically inhibit  the  lysis of TNBS-modified targets  by effector cells 
generated against TNBS-modified syngeneic cells. To test the blocking ability of 
TNBS-modified  and  TSD-modified  syngeneic  cells,  effectors generated  by in P.  A.  HENKART~  A-M.  SCHMITT-VERHULST,  AND  G.  M.  SHEARER 
TABLE  IX 
Comparison of TNP-Modified Cells as CML Stimulators and Spleen  Targets 
1073 
Sensitization 
Stimulator  Responder 
Percent  specific  lysis  ±  SE on targets  and at effector:target  ratios shown: 
-  B10.BR 
B10.BR-TNBS, l0  B10.BR 
mM 
B10.BR-TNBS, 1 mM  B10.BR 
B10.BR-TSD  B10.BR 
B10.BR-TSD  B10.BR 
(Restirn)$ 
-  B1O 
B10,BR  B1O 
Exp.  1 
RDM-4-TNBS, 1O mM  RDM-4-TSD  RDM-4 
(40:1)  (4@.1)  (40:1) 
[12.7]  [17.5]  [3.9] 
42.6 ±  2.0  -8.0 ±  1.7  -5.5 ±  1.6 
39.5 ±  3.1  -1.3 ±  2.7  -4.5 ±  2.0 
-8.0 ±  1.9  -6.0 ±  2.8  -3.7 ±  1.7 
-7.1 ±  2.0  -9.2 ±  1.9  -5.3 ±  1.9 
(4:1)  (4:1)  (4:1) 
[1.9]  [0.6]  [-4.5] 
26.9 -+ 0.7  44.3 ±  3.8  48.1 ±  3.4 
Exp 2 
B10.BR Spleen-TNBS, 10 mM  B10.BR Spleen-TSD 
(40:1)  (20:1)  (10:1)  (40:1)  (20:1)  (10:1) 
-  B10.BR  [12.7]  [6.7]  [6.7]  [-4.0]  [-6.1]  [-6.1] 
B10.BR-TNBS  B10.BR  23.6 ±  4.7  25.2 ±  2.1  18,9 ±  4.3  -2.5 ±  2.3  1.8 -+  1.9  -1.9 ±  1.5 
B10.BR-TSD  B10.BR  -0.7 ±  2.5  -6.0 ±  1.4  -5,1 ±  1.8  -1.2 ±  1.6  0.5 -+ 1.6  -1.1 ±  1.7 
EL-4 
(4:1)  (2:1)  (1:1) 
-  BI0.BR  [3.8]  [2.0]  [1.3] 
BI0  BI0.BR  80.6 ±  4.1  68.7 ±  3.5  43.3 ±  2.6 
BI0-TSD  BI0.BR  81.4 ±  4.3  65.9  ±  4.3  46.6  ±  4.0 
* Specific lysis was calculated by subtracting the lysis by unstimulated cultured cells (shown in brackets) from the total lysis. Spontaneous 
]ysis of the target ceils was 19.5, 24.4, and 20.9%, respectively. 
$ Responder cells restimulated with 3  ×  I0' BI0.BR-TSD spleen cells alter 24 h of culture. Effector:.target cell ratio =  20:1. 
vitro  sensitization against TNBS-modified syngeneic spleen  cells were  incu- 
bated for 30 min at 37°C with different numbers of  unlabeled RDM-4 tumor cells, 
which were unmodified, modified with 10, 1, or 0.1 mM TNBS, or were modified 
with TSD. 51Cr-labeled  RDM-4-TNP target cells were then added to the blocking 
effector cell mixture and centrifuged for 3 min at 400 rpm. The blocking effector 
target  cell  mixture was  incubated for 31/2 h  for the 51Cr-release  assay.  The 
results of two independent experiments are summarized in Table III and Fig. 
3. No inhibition of lysis was detected in the presence of 0.1 mM TNBS-modified 
RDM-4  or  RDM-4-TSD  blocking  cells  above  that  observed  when  the  same 
number of unmodified RDM-4 cells were used. In the first experiment of Table 
III and  in Fig.  3  some nonspecific inhibition of lysis was observed with the 
highest concentration of unmodified RDM-4 cells. Inhibition of lysis with 10 mM 
TNBS-modified blocking cells  was  consistently more  effective than that  ob- 
served  with  1  mM  TNBS-modified blocking cells.  Thus,  RDM-4  tumor cells 
modified with 10 or 1 mM TNBS inhibited the lysis of TNBS-modified target 
cells by the relevant effectors, whereas the TSD-modified RDM-4 cells which 
presented equivalent amounts of  TNP on the cell surface did not inhibit lysis. 
It is also noteworthy that when soluble TSD was allowed to interact with 
sensitized anti-self TNP effector cells for 30 min before the addition of TNBS- 1074  CELL-MEDIATED  LYMPHOLYSIS  SPECIFIC  TO  TRINITROPHENYL  SELF 
TABLE  III 
Comparison of the Blocking of Cytotoxicity Against TNBS-Modified Targets with TNP- 
Modified and TSD-Modified Inhibiting  Cells 
Respond- 
ing and 
Exp.  TNBS-  Blocking cells 
no.  modified 
stimulat- 
ing cells 
Percent specific lysis at blocking:effector cell 
ratios of: 
1  BIO.A  (4:1)  (1:1)  (1:4) 
RDM-4  10.5  +- 4.0  35.2  -+ 4.0  47.3  +-- 6.5 
RDM-4-TNBS, 10mM  23.9  -+ 3.5  8.1  +_  1.7  23.0  _+  2.6 
RDM-4-TNBS,  1 mM  32.3  _+  1.9  20.6  -+ 3.3  30.1  _+  4.5 
RDM-4-TSD  46.4  _+  5.3  45.4  _+  5.7 
2  B10.BR  (2:1)  (1:1)  (1:2) 
RDM-4  45.9  -+ 2.6  47.1  -+ 4.1  51.6  _+ 3.7 
RDM-4-TNBS, 10 mM  6.2  _+  0.7  12.5  -+  1.0  21.0  _+  1.6 
RDM-4-TNBS,  1 mM  24.7  _+  1.4  32.7  -+  1.5  34.2  _+  2.6 
RDM-4-TSD  39.0 +-  1.0  41.6  _+  1.6  45.9  _  2.1 
Number of effector cells per well was 2.5  ×  l0  p.  Effector:target cell ratio was 20:1. 
Target cell was RDM-4-TNBS (10 raM). 
Specific  lysis in the absence of blocking cells was 38.6  -+  4.7  and 53.3  -+  1.2 for exps.  1  and  2, 
respectively. 
treated tumor target cells, the presence of an excess of soluble TSD in the lytic 
assay did not affect the extent of lysis (data not shown). These results suggest 
that  neither  TNP presented on syngeneic cells via stearoyl dextran  nor TSD 
bound to the effector cells themselves are able to interact with high avidity with 
the receptor(s) involved in the H-2-associated recognition of TNBS-modified self 
by effectors generated against TNBS-modified syngeneic cells. 
Discussion 
Allogeneic cytotoxic effector cells, for which the response is directed against 
the natural H-2 products, can be generated in a primary in vitro CML (10,  11). 
Similarly, haptens covalently linked to lymphocyte surface proteins appear to be 
capable of eliciting primary in vitro T-cell-mediated cytotoxic responses (1-5). In 
these  examples,  the  specificity  of the  effector  cells  generated  was  directed 
against  products of the K  and D  regions of the H-2  complex  (1,  2,  4,  5).  The 
question can be raised whether covalent modification of cell surface proteins 
(possibly H-2  products)  with  TNP  is  a  requirement  for  the  generation  of a 
primary  in  vitro  CML.  The  use  of an  amphipathic  molecule  such  as  TNP 
stearoyl dextran,  which can be inserted into the lipid bilayer of the cell mem- 
brane  provides a  system for investigating  this  question.  Both the covalently- 
modified (TNBS-treated) cells and the TSD-modified cells (in which the hapten 
is not covalently linked to the cell surface proteins) provide equivalent amounts 
of the same TNP hapten exposed on the cell surface. Thus, in the present study 
it was demonstrated that the failure of TSD-modified cells to generate cytotoxic 
effectors, or to be recognized by the TNBS-modified self effectors is not due to a 
quantitative  deficiency in the number of cell surface TNP groups accessible to P.  A.  HENKART,  A-M.  8CHMITT-VERHULST,  AND  G.  M.  SHEARER 
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FIG.  3.  Inhibition of the  lysis of RDM-4-TNP-modified ~'Cr-labeled targets  by BI0.BR 
effectors by using TNBS- or TSD-modified, unlabeled RDM-4 blocking cells. The effector 
cells were generated by incubating B10.BR spleen cells with TNP-modified B10.BR cells for 
5 days. Blocking cells were: RDM-4-TNBS (10 mM), (@); RDM-4-TNBS (1 mM), (@); RDM-4- 
TNBS (0.1 raM), (V); RDM-4-TSD (V). The specific cytotoxic response without blocking was 
32.7  -  6.1%.  Nonspecific lysis by unsensitized cultured cells was 11.0%.  Effector:target cell 
ratio =  20:1; target cells per well -  1.25  ×  104. 
anti-TNP. These results imply that there may need to be a covalent linkage 
between the hapten and the proteins (possibly  H-2 antigens) on the cell  surface 
for efficient  recognition to occur. 
The loss  of some of the TSD  molecules from the spleen cells  after  24 h of 
incubation could have prevented TSD-modified cells  from sensitizing  the cul- 
tures (perhaps even when the cultures were restimulated with TSD-modified 
cells,  as in line  5 of  Table II).  We have shown, however, that the stability  of  cell 
surface TSD, although not as great as TNP  self  proteins,  is still  adequate to 
provide more than enough TNP  groups for target cell  recognition during the 
CML  assay. We have furthermore sought to  eliminate questions of  the  failure  of 
this  recognition being due to instability  of  TNP groups on TSD by using spleen 
cell targets having more stable  TSD  and by performing cold  target blocking 
studies. 
Two models have been proposed for  the recognition of  TNP self  by effector  T 
cells  (12),  differing  in  the number of  independent receptors  on  the  T-cell  surface. 
In  the first  model, known as  the altered  self  recognition model, the effector  cells 
possess a single receptor recognizing  self  major histocompatibility complex 1076  CELL-MEDIATED  LYMPHOLYSIS  SPECIFIC  TO  TRINITROPHENYL  SELF 
products  which have been  altered by the  hapten  (1,  12). The  second,  dual 
recognition model, proposes that the effector cells possess two separate recep- 
tors, one for hapten, and one for unaltered self MHC complex components (12). A 
number of experiments attempting to distinguish between these two alterna- 
tives  have been performed (3-5,  12-14) and some of these suggest that the 
altered self model may be more likely, although definitive proof is still lacking. 
The present results are also more readily explained by the altered self model. If, 
as indicated above for the dual recognition model, two independent receptors 
exist on the effector cell surface, TSD-modified cells might be expected to be 
recognized by the TNBS self elicited effector cells, since we have shown that 
they possess  equivalent TNP hapten and also MHC  antigens recognizable by 
allogeneic effector cells (Table II, line 7). The failure of recognition in this case 
does not necessarily exclude the dual recognition model, since it could be argued 
that the TNP receptor has some steric requirements not met by cell surface TSD, 
or that the TNP receptor shows specificity for more than just the hapten and 
includes several neighboring amino acids (in addition to its other, MHC deter- 
minant receptor). The latter possibility appears plausible as suggested by the 
experiments of Janeway et al. (15). If neighboring amino acids for self antigens 
are included as part of the hapten and are recognized by the haptenic receptor, 
then it must be postulated that self components (even if they constitute only a 
few amino acids adjacent to the hapten) are involved in the specificity for both 
receptors of the  dual recognition model.  In  such a  model,  TNP-altered self 
components would comprise one of the two receptors. 
The  experiments described in  this  report  provide  an  extension of earlier 
investigations concerned with the fine specificity associated with the in vitro 
TNP-modified self CML (2-5, 16), and illustrate the versatility of this system for 
studying such issues. Similar to the interpretation from a previous report (3), 
the results are more compatible with a single than a dual receptor model, if it is 
assumed that the TNP group defines the hapten. 
Summary 
Mouse splenic lymphocytes and lymphoid tumor cells were modified with the 
trinitrophenyl (TNP) group either by treatment with trinitrobenzene sulfonate 
(TNBS)  (which covalently modifies cell surface proteins) or with TNP stearoyl 
dextran  (TSD)  (which binds  to  the  cell  by  noncovalent forces).  These  cell 
preparations were compared for their ability to: (a) sensitive syngeneic splenic 
lymphocytes leading to the generation of cytotoxic effector cells;  (b) serve as 
lysable targets in a 4-h 51Cr-release assay for effector cells generated in (a); and 
(c) act as blocking cells in the lysis of TNBS-medified targets lysed by TNP self 
effector cells generated in (a). In none of these three experimental systems did 
TSD-medified syngeneic spleen or H-2-matched tumor cells act either as  a 
sensitizing immunogen or as a target antigen, despite the demonstration that 
quantitatively equivalent mounts of TNP were exposed on the cell surface in 
the TNBS- and TSD-modified cells.  In contrast, TNBS-modified spleen cells 
sensitized syngeneic lymphocytes to generate effectors against TNBS-modified 
syageneic targets. Furthermore, TNBS-modified, H-2-matched cells served as 
specific lysable targets and as inhibiting cells for such effeetors. These results P.  A.  HENKART,  A-M.  SCHMITT-VERHULST,  AND  G.  M.  SHEARER  1077 
indicate that the manner in which TNP  is associated with the cell  surface is 
important in  the  immunogenicity and antigenicity  ofhapten-modified syngeneic 
stimulating  cells  in  generatingH-2-associated cell-mediated lympholysis (CML) 
reactions.  These findings raise  the  possibility  that  a covalent  or  at  least  a stable 
linkage with cell  surface proteins (possibly  H-2-controlled products) is impor- 
tant for immunological function.  Furthermore, these observations do not favor 
the dual receptor model for  H-2-restricted syngeneic CML  if  it is assumed in 
such a model that  one receptor is  specific  for  the  TNP moiety and the second for 
unmodified self  major histocompatibility products. 
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Received for publication 28 February 1977. 
References 
1.  Shearer, G. M. 1974. Cell-mediated cytotoxicity to trinitrophenyl-modified  syngeneic 
lymphocytes. Eur. J. Irnmunol. 4:527. 
2.  Rehn, T.  G.,  G. M. Shearer, H.  S.  Koren, and J.  K. Inman. 1976. Cell-mediated 
lympholysis  of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-B-alanylglycylglycyl-modi- 
fled autologous lymphecytes. Effector cell specificity to modified cell surface compo- 
nents controlled  by the H-2K and H-2D serological regions  of the murine major 
histocompatibility complex. J. Exp. Med. 143:127. 
3.  Rehn, T. G., J. K. Inman, and G. M. Shearer. 1976. Cell-mediated lympholysis toH- 
2-matched target cells modified with a series ofnitrophenyl  compounds. J. Exp. Med. 
144:1134. 
4.  Shearer, G. M., T. G. Rehn, and C. A. Garbarino.  1975. Cell-mediated lympholysis of 
trinitrophenyl-modified  autologous lymphocytes. Effector cell specificity to modified 
cell surface components controlled by the H-2K and H-2D serological regions of the 
murine major histocompatibility complex. J. Exp. Med. 141:1348. 
5.  Forman, J. 1975. On the role of the H-2 histocompatibility complex in determining 
the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl- 
modified targets. J. Exp. Med.  142:403. 
6.  Okuyama, T.,  and K.  Satake.  1960. On  the preparation and properties  of 2,4,6 
trinitrophenyl-amino acids and -peptides. J. Biochern.  (Tokyo).  47:454. 
6a.  Wolf, D.  E., J.  E.  Schiessinger,  E.  L. Elson,  W.  W.  Webb, R. Blumenthal, and 
P. Henkart. 1977. Diffusion and patching of macromolecules on planar lipid bilayer 
membranes. Biochemistry.  16:3476. 
7.  Inman,  J.  K.  1975. Thymus-independent antigens:  The  preparation  of covalent 
hapten-ficoll linkages. J. Immunol.  114:704. 
8.  Lapidot,  Y., S. Rapport,  and Y. Wolman. 1967. Use of esters of N-hydroxy-succini- 
mide in the synthesis of N-acylamino acids. J. Lipid Res. 8:142. 
9.  Loken,  M.  R.,  and L.  A.  Herzenberg.  1975. Analysis of cell  populations  with a 
fluorescence activated cell sorter. Ann. N.Y. Acad. Sei. 254:163. 
10.  Hiiyry, P., and V. Defendi. 1970. Mixed lymphocyte cultures produce effector cells: 
An in vitro model for allograft rejection. Science  (Wash. D.C.). 168:133. 
11.  Wunderlich, J. R., and T. G. Canty. 1970. Cell-mediated immunity induced in vitro. 
Nature (Lond.). 228:63. 
12.  Zinkernagel, R. M., and P.  C. Doherty.  1974. Immunological  surveillance against 1078  CELL-MEDIATED  LYMPHOLYSIS  SPECIFIC  TO  TRINITROPHENYL  SELF 
altered self components by sensitized T lymphocytes in lymphocytic choriomeningi- 
tis. Nature (Lond.). 251:547, 
13.  Pfizenmayer, K., A. Starzinski-Powitz,  H.  Rodt, M. R611inghoff, and H. Wagner. 
1976. Virus and trinitrophenol hapten-specific T-cell-mediated cytotoxicity against 
H-2 incompatible target cells. J. Exp. Med.  143:999. 
14.  yon Boehmer, H., and W. Haas. 1976. Cytotexic T lymphocytes recognize aUogeneic 
tolerated TNP-conjugated cells. Nature (Lond.). 261:141. 
15.  Janeway, C.  A.,  Jr.,  P.  H.  Maurer,  M.  O.  Dailey,  and J.  K.  Inman.  1976. The 
specificity of  cellular immune responses in guinea pigs. II. The structure of antigenic 
determinants leading to T-lymphocyte stimulation. J. Exp. Med.  144:1621. 
16.  Schmitt-Verhulst, A., D. Sachs, and G. M. Shearer. 1976. Cell-mediated lympholysis 
of trinitrophenyl-modified  autologous lymphocytes. Confirmation of genetic control 
of  response to trinitrophenyl-medified  H-2 antigens by the use of  anti-H-2 and anti-Ia 
antibodies. J. Exp. Med. 143:211. 